ResearcherGifu Municipal HospitalNo recent work listed
Junji Kawaguchi
Matched on OpenAlex author ID A5000062642. Sources: OpenAlex.
Their work
- Papers
- 8
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2011: 4 papers · 2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 2 papers · 2017: 1 paper
Papers 8
- A multicenter prospective phase II study of first-line modified FOLFIRINOX for unresectable advanced pancreatic cancer. Co-author DOI 10.18632/oncotarget.22795↗
- The significance of phosphorylated heat shock protein 27 on the prognosis of pancreatic cancer. Co-author DOI 10.18632/oncotarget.7424↗
- Anticancer effect of arsenite on cell migration, cell cycle and apoptosis in human pancreatic cancer cells. Co-author DOI 10.3892/ol.2016.4564↗
- UVC irradiation suppresses platelet-derived growth factor-BB-induced migration in human pancreatic cancer cells. Co-author DOI 10.3892/or.2011.1612↗
- Ultraviolet enhances the sensitivity of pancreatic cancer cells to gemcitabine by activation of 5' AMP-activated protein kinase. Co-author DOI 10.1016/j.bbrc.2011.09.020↗
- Phosphorylation status of heat shock protein 27 plays a key role in gemcitabine-induced apoptosis of pancreatic cancer cells. Co-author DOI 10.1016/j.canlet.2011.09.008↗
- Inhibition of Rho-associated coiled-coil containing protein kinase enhances the activation of epidermal growth factor receptor in pancreatic cancer cells. Co-author DOI 10.1186/1476-4598-10-79↗
- UVC radiation induces downregulation of EGF receptor via phosphorylation at serine 1046/1047 in human pancreatic cancer cells. Co-author DOI 10.1667/rr2445.1↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Seiji Adachi · 7 shared papers, 2011–2016 · strength 0.25
- Paper Anticancer effect of arsenite on cell migration, cell cycle and apoptosis in human pancreatic cancer cells. DOI 10.3892/ol.2016.4564↗
- Paper The significance of phosphorylated heat shock protein 27 on the prognosis of pancreatic cancer. DOI 10.18632/oncotarget.7424↗
- Paper UVC irradiation suppresses platelet-derived growth factor-BB-induced migration in human pancreatic cancer cells. DOI 10.3892/or.2011.1612↗
- Osamu Kozawa · 7 shared papers, 2011–2016 · strength 0.25
- Paper Anticancer effect of arsenite on cell migration, cell cycle and apoptosis in human pancreatic cancer cells. DOI 10.3892/ol.2016.4564↗
- Paper The significance of phosphorylated heat shock protein 27 on the prognosis of pancreatic cancer. DOI 10.18632/oncotarget.7424↗
- Paper UVC irradiation suppresses platelet-derived growth factor-BB-induced migration in human pancreatic cancer cells. DOI 10.3892/or.2011.1612↗
- Ichiro Yasuda · 7 shared papers, 2011–2016 · strength 0.25
- Paper Anticancer effect of arsenite on cell migration, cell cycle and apoptosis in human pancreatic cancer cells. DOI 10.3892/ol.2016.4564↗
- Paper The significance of phosphorylated heat shock protein 27 on the prognosis of pancreatic cancer. DOI 10.18632/oncotarget.7424↗
- Paper UVC irradiation suppresses platelet-derived growth factor-BB-induced migration in human pancreatic cancer cells. DOI 10.3892/or.2011.1612↗
- Hisataka Moriwaki · 7 shared papers, 2011–2016 · strength 0.25
- Paper Anticancer effect of arsenite on cell migration, cell cycle and apoptosis in human pancreatic cancer cells. DOI 10.3892/ol.2016.4564↗
- Paper The significance of phosphorylated heat shock protein 27 on the prognosis of pancreatic cancer. DOI 10.18632/oncotarget.7424↗
- Paper UVC irradiation suppresses platelet-derived growth factor-BB-induced migration in human pancreatic cancer cells. DOI 10.3892/or.2011.1612↗
- Takahiro Yamauchi · 6 shared papers, 2011–2016 · strength 0.19
- Paper Anticancer effect of arsenite on cell migration, cell cycle and apoptosis in human pancreatic cancer cells. DOI 10.3892/ol.2016.4564↗
- Paper UVC irradiation suppresses platelet-derived growth factor-BB-induced migration in human pancreatic cancer cells. DOI 10.3892/or.2011.1612↗
- Paper Ultraviolet enhances the sensitivity of pancreatic cancer cells to gemcitabine by activation of 5' AMP-activated protei… DOI 10.1016/j.bbrc.2011.09.020↗
- Masahito Shimizu · 3 shared papers, 2016–2017 · strength 0.18
- Paper A multicenter prospective phase II study of first-line modified FOLFIRINOX for unresectable advanced pancreatic cancer. DOI 10.18632/oncotarget.22795↗
- Paper Anticancer effect of arsenite on cell migration, cell cycle and apoptosis in human pancreatic cancer cells. DOI 10.3892/ol.2016.4564↗
- Paper The significance of phosphorylated heat shock protein 27 on the prognosis of pancreatic cancer. DOI 10.18632/oncotarget.7424↗
- Masanori Nakashima · 5 shared papers, 2011–2016 · strength 0.15
- Paper The significance of phosphorylated heat shock protein 27 on the prognosis of pancreatic cancer. DOI 10.18632/oncotarget.7424↗
- Paper Ultraviolet enhances the sensitivity of pancreatic cancer cells to gemcitabine by activation of 5' AMP-activated protei… DOI 10.1016/j.bbrc.2011.09.020↗
- Paper Phosphorylation status of heat shock protein 27 plays a key role in gemcitabine-induced apoptosis of pancreatic cancer … DOI 10.1016/j.canlet.2011.09.008↗
- Takashi Yoshioka · 5 shared papers, 2011–2012 · strength 0.13
- Paper UVC irradiation suppresses platelet-derived growth factor-BB-induced migration in human pancreatic cancer cells. DOI 10.3892/or.2011.1612↗
- Paper Ultraviolet enhances the sensitivity of pancreatic cancer cells to gemcitabine by activation of 5' AMP-activated protei… DOI 10.1016/j.bbrc.2011.09.020↗
- Paper Phosphorylation status of heat shock protein 27 plays a key role in gemcitabine-induced apoptosis of pancreatic cancer … DOI 10.1016/j.canlet.2011.09.008↗
- Mitsuru Okuno · 2 shared papers, 2016–2017 · strength 0.12
- Takuji Iwashita · 2 shared papers, 2016–2017 · strength 0.12
- Kensaku Yoshida · 1 shared paper, 2017 · strength 0.07
- Akinori Maruta · 1 shared paper, 2017 · strength 0.07
- Shinya Uemura · 1 shared paper, 2017 · strength 0.07
- Yohei Horibe · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.